Lyell Immunopharma (LYEL) FCF Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138.74 Mn |
| Dec 31, 2025 | -35.17 Mn |
| Sep 30, 2025 | 24.30 Mn |
| Jun 30, 2025 | 35.02 Mn |
| Mar 31, 2025 | -35.72 Mn |
| Dec 31, 2024 | -32.37 Mn |
| Sep 30, 2024 | 19.23 Mn |
| Jun 30, 2024 | 110.60 Mn |
| Mar 31, 2024 | -108.87 Mn |
| Dec 31, 2023 | -16.22 Mn |
| Sep 30, 2023 | -692,000.00 |
| Jun 30, 2023 | -7.20 Mn |
| Mar 31, 2023 | -7.17 Mn |
| Dec 31, 2022 | 132.98 Mn |
| Sep 30, 2022 | -132.96 Mn |
| Jun 30, 2022 | 850,148.00 |
| Mar 31, 2022 | -536,688.00 |
| Dec 31, 2021 | -376,709.00 |
| Sep 30, 2021 | 268,345.00 |
| Jun 30, 2021 | -6,302.00 |
| Mar 31, 2021 | -160,223.00 |
| Dec 31, 2020 | 334,877.00 |